Effects of L-arginine on the proliferation of T lymphocyte subpopulations

J. B. Ochoa, J. Strange, P. Kearney, G. Gellin, E. Endean, Elizabeth Fitzpatrick

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Background: Dietary supplementation of L-arginine as a mechanism to enhance cellular immune response (T lymphocytes), has slowly gained approval, and appears especially important during critical illness. Despite its clinical use, little is known as to the direct effects of L-arginine on the different T lymphocyte subpopulations. Methods: Lymphocytes were harvested from spleens of C57 B1/6 mice, and proliferation was induced with anti-CD3 in the presence of different concentrations of L-arginine ranging from 0 to 1000 μmol/L. Flow cytometry was used to evaluate the effect of L-arginine on T lymphocyte subpopulations. Interleukin-2 production was measured by ELISA and gene expression by RT-PCR. Results: L-Arginine at or greater than 100 μmol/L significantly enhanced anti-CD3 stimulated T lymphocyte proliferation (p = .01). L-Arginine was essential for adequate T lymphocyte (CD3+) cellular maturation (p = .01). Proliferation of Helper T cell (CD4+) was not dependent on L-arginine. In contrast, Cytotoxic T cell (CD8+) showed a dose dependent proliferation in response to L-arginine (p = .01). Of the CD8+ cells, an increase in the CD45RA negative CD8 positive (memory) T cell subpopulation was observed with the addition of L-arginine. In addition, the number of cell surface CD8 receptors (CD8R) and CD3 receptors (CD3R) increased in the presence of L-arginine (p = .01, p = .04). Interleukin-2 receptor (IL-2R) expression was not up-regulated by L-arginine. L-Arginine modestly increased IL-2 production and had pronounced effects on its disappearance from the culture media (p < .0001). Interleukin-2 mRNA expression was not dependent on L-arginine. Conclusions: The requirements for L-arginine for the proliferation of CD3 stimulated T lymphocytes vary widely, and have to be taken into account when studying the mechanism of how L-arginine enhances cellular proliferation. L-Arginine may increase cellular proliferation by increasing specific receptor expression and the utilization of interleukin-2.

Original languageEnglish (US)
Pages (from-to)23-29
Number of pages7
JournalJournal of Parenteral and Enteral Nutrition
Volume25
Issue number1
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

Fingerprint

Lymphocyte Subsets
Arginine
T-Lymphocytes
Interleukin-2
Cell Proliferation
Interleukin-2 Receptors
Cell Surface Receptors
Dietary Supplements
Helper-Inducer T-Lymphocytes
Critical Illness
Cellular Immunity

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Effects of L-arginine on the proliferation of T lymphocyte subpopulations. / Ochoa, J. B.; Strange, J.; Kearney, P.; Gellin, G.; Endean, E.; Fitzpatrick, Elizabeth.

In: Journal of Parenteral and Enteral Nutrition, Vol. 25, No. 1, 01.01.2001, p. 23-29.

Research output: Contribution to journalArticle

Ochoa, J. B. ; Strange, J. ; Kearney, P. ; Gellin, G. ; Endean, E. ; Fitzpatrick, Elizabeth. / Effects of L-arginine on the proliferation of T lymphocyte subpopulations. In: Journal of Parenteral and Enteral Nutrition. 2001 ; Vol. 25, No. 1. pp. 23-29.
@article{905054a341f04d6e8509d896cb83c97b,
title = "Effects of L-arginine on the proliferation of T lymphocyte subpopulations",
abstract = "Background: Dietary supplementation of L-arginine as a mechanism to enhance cellular immune response (T lymphocytes), has slowly gained approval, and appears especially important during critical illness. Despite its clinical use, little is known as to the direct effects of L-arginine on the different T lymphocyte subpopulations. Methods: Lymphocytes were harvested from spleens of C57 B1/6 mice, and proliferation was induced with anti-CD3 in the presence of different concentrations of L-arginine ranging from 0 to 1000 μmol/L. Flow cytometry was used to evaluate the effect of L-arginine on T lymphocyte subpopulations. Interleukin-2 production was measured by ELISA and gene expression by RT-PCR. Results: L-Arginine at or greater than 100 μmol/L significantly enhanced anti-CD3 stimulated T lymphocyte proliferation (p = .01). L-Arginine was essential for adequate T lymphocyte (CD3+) cellular maturation (p = .01). Proliferation of Helper T cell (CD4+) was not dependent on L-arginine. In contrast, Cytotoxic T cell (CD8+) showed a dose dependent proliferation in response to L-arginine (p = .01). Of the CD8+ cells, an increase in the CD45RA negative CD8 positive (memory) T cell subpopulation was observed with the addition of L-arginine. In addition, the number of cell surface CD8 receptors (CD8R) and CD3 receptors (CD3R) increased in the presence of L-arginine (p = .01, p = .04). Interleukin-2 receptor (IL-2R) expression was not up-regulated by L-arginine. L-Arginine modestly increased IL-2 production and had pronounced effects on its disappearance from the culture media (p < .0001). Interleukin-2 mRNA expression was not dependent on L-arginine. Conclusions: The requirements for L-arginine for the proliferation of CD3 stimulated T lymphocytes vary widely, and have to be taken into account when studying the mechanism of how L-arginine enhances cellular proliferation. L-Arginine may increase cellular proliferation by increasing specific receptor expression and the utilization of interleukin-2.",
author = "Ochoa, {J. B.} and J. Strange and P. Kearney and G. Gellin and E. Endean and Elizabeth Fitzpatrick",
year = "2001",
month = "1",
day = "1",
doi = "10.1177/014860710102500123",
language = "English (US)",
volume = "25",
pages = "23--29",
journal = "Journal of Parenteral and Enteral Nutrition",
issn = "0148-6071",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Effects of L-arginine on the proliferation of T lymphocyte subpopulations

AU - Ochoa, J. B.

AU - Strange, J.

AU - Kearney, P.

AU - Gellin, G.

AU - Endean, E.

AU - Fitzpatrick, Elizabeth

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Background: Dietary supplementation of L-arginine as a mechanism to enhance cellular immune response (T lymphocytes), has slowly gained approval, and appears especially important during critical illness. Despite its clinical use, little is known as to the direct effects of L-arginine on the different T lymphocyte subpopulations. Methods: Lymphocytes were harvested from spleens of C57 B1/6 mice, and proliferation was induced with anti-CD3 in the presence of different concentrations of L-arginine ranging from 0 to 1000 μmol/L. Flow cytometry was used to evaluate the effect of L-arginine on T lymphocyte subpopulations. Interleukin-2 production was measured by ELISA and gene expression by RT-PCR. Results: L-Arginine at or greater than 100 μmol/L significantly enhanced anti-CD3 stimulated T lymphocyte proliferation (p = .01). L-Arginine was essential for adequate T lymphocyte (CD3+) cellular maturation (p = .01). Proliferation of Helper T cell (CD4+) was not dependent on L-arginine. In contrast, Cytotoxic T cell (CD8+) showed a dose dependent proliferation in response to L-arginine (p = .01). Of the CD8+ cells, an increase in the CD45RA negative CD8 positive (memory) T cell subpopulation was observed with the addition of L-arginine. In addition, the number of cell surface CD8 receptors (CD8R) and CD3 receptors (CD3R) increased in the presence of L-arginine (p = .01, p = .04). Interleukin-2 receptor (IL-2R) expression was not up-regulated by L-arginine. L-Arginine modestly increased IL-2 production and had pronounced effects on its disappearance from the culture media (p < .0001). Interleukin-2 mRNA expression was not dependent on L-arginine. Conclusions: The requirements for L-arginine for the proliferation of CD3 stimulated T lymphocytes vary widely, and have to be taken into account when studying the mechanism of how L-arginine enhances cellular proliferation. L-Arginine may increase cellular proliferation by increasing specific receptor expression and the utilization of interleukin-2.

AB - Background: Dietary supplementation of L-arginine as a mechanism to enhance cellular immune response (T lymphocytes), has slowly gained approval, and appears especially important during critical illness. Despite its clinical use, little is known as to the direct effects of L-arginine on the different T lymphocyte subpopulations. Methods: Lymphocytes were harvested from spleens of C57 B1/6 mice, and proliferation was induced with anti-CD3 in the presence of different concentrations of L-arginine ranging from 0 to 1000 μmol/L. Flow cytometry was used to evaluate the effect of L-arginine on T lymphocyte subpopulations. Interleukin-2 production was measured by ELISA and gene expression by RT-PCR. Results: L-Arginine at or greater than 100 μmol/L significantly enhanced anti-CD3 stimulated T lymphocyte proliferation (p = .01). L-Arginine was essential for adequate T lymphocyte (CD3+) cellular maturation (p = .01). Proliferation of Helper T cell (CD4+) was not dependent on L-arginine. In contrast, Cytotoxic T cell (CD8+) showed a dose dependent proliferation in response to L-arginine (p = .01). Of the CD8+ cells, an increase in the CD45RA negative CD8 positive (memory) T cell subpopulation was observed with the addition of L-arginine. In addition, the number of cell surface CD8 receptors (CD8R) and CD3 receptors (CD3R) increased in the presence of L-arginine (p = .01, p = .04). Interleukin-2 receptor (IL-2R) expression was not up-regulated by L-arginine. L-Arginine modestly increased IL-2 production and had pronounced effects on its disappearance from the culture media (p < .0001). Interleukin-2 mRNA expression was not dependent on L-arginine. Conclusions: The requirements for L-arginine for the proliferation of CD3 stimulated T lymphocytes vary widely, and have to be taken into account when studying the mechanism of how L-arginine enhances cellular proliferation. L-Arginine may increase cellular proliferation by increasing specific receptor expression and the utilization of interleukin-2.

UR - http://www.scopus.com/inward/record.url?scp=0035181437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035181437&partnerID=8YFLogxK

U2 - 10.1177/014860710102500123

DO - 10.1177/014860710102500123

M3 - Article

VL - 25

SP - 23

EP - 29

JO - Journal of Parenteral and Enteral Nutrition

JF - Journal of Parenteral and Enteral Nutrition

SN - 0148-6071

IS - 1

ER -